Skip to main content
Shenzhen Chipscreen Biosciences Co., Ltd. logo

Shenzhen Chipscreen Biosciences Co., Ltd. — Investor Relations & Filings

Ticker · 688321 ISIN · CNE100003LW0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 967 across all filing types
Latest filing 2025-11-19 Governance Information
Country CN China
Listing Shanghai Stock Exchange 688321

About Shenzhen Chipscreen Biosciences Co., Ltd.

https://www.chipscreen.com/en/

Shenzhen Chipscreen Biosciences Co., Ltd. specializes in the discovery and development of original small molecule innovative drugs. The company leverages its proprietary chemical genomics-based drug discovery and early evaluation platform to address unmet medical needs in oncology, metabolic diseases, and autoimmune disorders. Its portfolio includes Chidamide (Epidaza), a selective histone deacetylase (HDAC) inhibitor approved for peripheral T-cell lymphoma and advanced breast cancer, and Chiglitazar (Bilessyl), a novel PPAR pan-agonist for type 2 diabetes. Chipscreen Biosciences maintains an integrated R&D system covering drug discovery, clinical development, and commercialization, focusing on molecular mechanisms and translational medicine to provide novel therapeutic solutions.

Recent filings

Filing Released Lang Actions
深圳微芯生物科技股份有限公司董事会议事规则（2025年11月）
Governance Information Classification · 100% confidence The document is titled '董事会议事规则' which translates to 'Board Meeting Rules' or 'Rules of Procedure for the Board of Directors' of Shenzhen Microchip Biotechnology Co., Ltd. The content details the procedures, responsibilities, meeting types, voting rules, and other governance-related protocols for the company's board of directors. It references company law and the company's articles of association, and it is a governance document outlining internal rules and board structure. There is no financial data, no audit information, no earnings or capital updates, no voting results, no legal proceedings, and no mention of shareholder meetings or reports. This fits the definition of a Governance Information report, which details the company's internal rules, board structure, and governance practices.
2025-11-19 Chinese
深圳微芯生物科技股份有限公司信息披露管理制度（2025年11月）
Governance Information Classification · 95% confidence The document is a comprehensive information disclosure management system of Shenzhen Microchip Biotechnology Co., Ltd. It details the company's policies, procedures, and responsibilities regarding information disclosure, including legal references, types of reports (annual, interim, quarterly, and temporary reports), disclosure obligations, internal reporting, confidentiality, and penalties. It is a governance document outlining internal rules and practices for information disclosure rather than an actual financial report or announcement. It does not contain financial statements, earnings data, or specific event announcements. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-11-19 Chinese
深圳微芯生物科技股份有限公司章程（2025年11月）
Governance Information Classification · 100% confidence The document is titled "章程" which translates to "Articles of Association" or "Company Bylaws." It contains detailed chapters about the company's general provisions, business scope, shares issuance and transfer, shareholders' rights and obligations, board of directors, senior management, financial accounting system, profit distribution, audit, notices and announcements, mergers, capital changes, dissolution, and amendments to the articles. The content is legal and governance-related, focusing on the internal rules, structure, and governance practices of the company. There is no indication of financial statements, audit reports, earnings data, or meeting results. The document is comprehensive and lengthy (15,000 characters), indicating it is the full text of the company's articles of association rather than a brief announcement or summary. Therefore, the most appropriate classification is Governance Information (CGR).
2025-11-19 Chinese
深圳微芯生物科技股份有限公司防范控股股东、实际控制人及其关联方占用公司资金的制度（2025年11月）
Governance Information Classification · 95% confidence The document is a detailed internal policy document from Shenzhen Microchip Biotechnology Co., Ltd. regarding the prevention of fund occupation by controlling shareholders, actual controllers, and their related parties. It outlines rules, responsibilities, and procedures to prevent misuse of company funds by related parties. There is no indication that this is a financial report, audit report, or announcement of voting results. It is not a certification or a brief announcement but a substantive governance-related policy document. The content aligns with governance practices and internal control mechanisms related to corporate governance. Therefore, the most appropriate classification is Governance Information (CGR). The document length is 2615 characters, which is substantive but not a full financial report, and the content is clearly about governance rules and procedures.
2025-11-19 Chinese
关于延长2024年度向特定对象发行A股股票所涉股东大会决议有效期及授权有效期的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Shenzhen Microchip Biotechnology Co., Ltd. regarding the extension of the validity period of a shareholder meeting resolution and authorization related to a specific issuance of A shares to particular investors in 2024. It details board meetings, shareholder meetings, and resolutions about the issuance plan and the extension of the authorization period. The document is short (1478 characters) and focuses on corporate governance and shareholder meeting resolutions related to capital issuance. It does not contain financial statements or detailed financial data, nor is it a full report or presentation. It is an official announcement about shareholder meeting resolutions and authorization validity periods, which fits the category of Capital/Financing Update (CAP) because it concerns the issuance of shares and related shareholder approvals and authorizations.
2025-11-19 Chinese
第三届董事会第十八次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at a board of directors meeting of Shenzhen Microchip Biotechnology Co., Ltd. It details the meeting date, attendance, and specific board decisions such as extending the validity of a shareholder meeting resolution, changes in registered capital, cancellation of the supervisory board, amendments to company bylaws, establishment of a wholly-owned subsidiary, and scheduling of an extraordinary general meeting. The document references that these resolutions will be submitted to the shareholders' meeting for approval and provides links to related announcements on the stock exchange website. The content is focused on board decisions and governance changes rather than full financial statements or detailed financial performance. The document length is relatively short (2348 characters) and it is a formal announcement of board meeting resolutions, not a full management report or annual/interim report. Therefore, the most appropriate classification is Board/Management Information (MANG).
2025-11-19 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.